Tolerability and Efficacy of Neoadjuvant Chemotherapy with a Tri-Weekly Interval Methotrexate, Doxorubicin, Vinblastine, and Cisplatin Regimen for Patients with Locally Advanced Bladder Cancer

Tolerability and Efficacy of Neoadjuvant Chemotherapy with a Tri-Weekly Interval Methotrexate, Doxorubicin, Vinblastine, and Cisplatin Regimen for Patients with Locally Advanced Bladder Cancer

Objective: Compared with standard treatment, a modified tri-weekly MVAC (methotrexate, doxorubicin, vinblastine, and cisplatin) treatment regimen with a high cisplatin dose intensity shows good efficacy and lower toxicity. Thus, we retrospectively investigated the tolerability and efficacy of a modi...

Full description

Bibliographic Details
Main Authors: Satoko Arai, Tomohiko Hara, Yoshiyuki Matsui, Keiichi Koido, Hironobu Hashimoto, Yasuo Shinoda, Motokiyo Komiyama, Hiroyuki Fujimoto, Hiroyuki Terakado
Format: Article
Language:English
Published: Karger Publishers 2018-07-01
Series:Case Reports in Oncology
Subjects:
Neoadjuvant chemotherapy
Modified MVAC
Muscle-invasive bladder cancer
Online Access:https://www.karger.com/Article/FullText/490458

Internet

https://www.karger.com/Article/FullText/490458

Similar Items